June has been a busy month for arthritis-related news. Here’s a wrap-up of the headlines from this past month.
Arthritis Foundation Releases Statement as Supreme Court Upholds Affordable Care Act
Earlier this month, the Supreme Court threw out a lawsuit that challenged the Affordable Care Act. The Arthritis Foundation issued a statement along with a letter of support from 33 other patient advocacy organizations. Read the statement.
Methotrexate Impairs COVID Vaccine Response
One-third of patients with immune-mediated inflammatory diseases being treated with methotrexate showed attenuated responses to the COVID-19 vaccine, researchers reported. Learn more.
The Complex Situation for the Immunocompromised and COVID-19 Vaccines
Studies suggest the available shots don’t provide enough protection, leaving more than 9 million Americans with compromised immune systems stuck in a waiting game. Find out more.
Testing Third Doses of COVID Vaccine in Immunocompromised Patients
New study offers hope for protecting this vulnerable population from COVID-19. Learn more about this study.
Get expert guidance on vaccine efficacy for people with compromised immune systems or on certain arthritis medications. Read more.
Diet May Impact COVID-19 Severity
Plant-based and/or fish diets may help lessen the severity of COVID-19 infection, according to a study published online June 7 in BMJ Nutrition Prevention & Health. Find out more about the study.
Following an anti-inflammatory diet, like the Mediterranean diet, may help reduce body-wide inflammation. Find out more.
New ACR Guidelines for Rheumatoid Arthritis Treatments Finalized
The American College of Rheumatology published its new 2020 guidelines for rheumatoid arthritis treatments, the first update since 2015. Read the new guidelines.
Get an expert breakdown of what the new ACR guidelines mean for patients with RA. Learn more.
Sleep Deprivation Linked With Cardiovascular Risk in Early Rheumatoid Arthritis
Patients with early rheumatoid arthritis have short sleep duration at night that is associated with cardiovascular disease risk factors, according to study findings published in ACR Open Rheumatology. Learn more.
Osteoarthritis Associated With Elevated Risk of Parkinson Disease
Researchers hypothesized that individuals with OA might be at higher risk of developing Parkinson’s disease. This is based on literature reporting that the peripheral inflammation associated with OA may cause neuroinflammation in the brain, leading to the neurodegeneration associated with Parkinson’s. Read more.
Combination Immunomodulatory Therapies for Patients With Psoriatic Arthritis?
An article in Arthritis & Rheumatology from psoriatic arthritis erudites, Drs. Scher, Ogdie, Merola and Ritchlin, is bringing attention to the discussion about combination therapy in the complex field of seronegative spondyloarthropathies — specifically psoriatic arthritis. Read more.